Unexpected Synthesis of Novel 3-Allyl-5-(arylidene)-2-thioxo-thiazolidin-4-ones in Reactions of 3-Allylrhodanine with 2-Arylidene-4-methyl-5-oxopyrazolidinium Ylides

REFERENCES

• Mentgen, T.; Steuer, C.; Klein, C. D. Privileged scaffolds or promiscuous binders: A comparative study on rhodanines and related heterocycles in medicinal chemistry, J. Med. Chem. 2012, 55, 743–753.
   PubMed Web of Science ®Google Scholar
• Khazaei, A.; Veisi, H.; Safaei, M.; Ahmadian, H. Green synthesis of 5-arylidene-2,4-thiazolidinedione, 5-benzylidene rhodanine, and dihydrothiophene derivatives catalyzed by hydrated ionic liquid tetrabutylammonium hydroxide in aqueous medium. J. Sulfur Chem. 2014, 35, 270–278.
   Web of Science ®Google Scholar
• Coulibaly, W. K.; Paquin, L.; Bénie, A.; Békro, Y-A.; Le Guével, R.; Ravache, M.; Corlu, A.; Bazureau, J. P. Prospective study directed to the synthesis of unsymmetrical linked bis-5-arylidene rhodanine derivatives via ‘‘one-pot two steps’’ reactions under microwave irradiation with their antitumor activity. Med. Chem. Res. 2014, 24, 1653–1661.
   Web of Science ®Google Scholar
• Tomasić, T.; Masic, L. P. Rhodanine as a privileged scaffold in drug discovery. Curr. Med Chem. 2009, 16, 1596–1629.
   PubMed Web of Science ®Google Scholar
• Bhatti, R. S.; Shah, S.; Suresh, S.; Krishan, P.; Sandhu, J. S. Recent pharmacological developments on rhodanines and 2,4-thiazolidinediones. Int. J. Med. Chem. 2013, 793260.
   Google Scholar
• Cutshall, N. S.; O’Day, C.; Prezhdo, M. Rhodanine derivatives as inhibitors of JSP-1. Bioorg. Med. Chem. Lett. 2005, 15, 3374–3382.
   PubMed Web of Science ®Google Scholar
• Hotta, N.; Akanuma, Y.; Kawamori, R.; Matsuoka, K.; Oka, Y.; Shichiri, M.; Toyata, T.; Nakoshima, M.; Yoshimura, I.; Sakamoto, N.; Shigeta, Y. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: The 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial. Diabetes Care 2006, 29, 1538–1541.
   PubMed Web of Science ®Google Scholar
• Maga, G.; Falchi, F.; Garbelli, A.; Belfiore, A.; Witvrow, M.; Manetti, F.; Botta, M. Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1: Replication targeting the human cellular aspartic acid–glutamic acid–alanine–aspartic acid box polypeptide 3. J. Med. Chem. 2008, 51, 6635–6638.
   PubMed Web of Science ®Google Scholar
• Bourahla, K.; Derdour, A.; Rahmouni, M.; Carreaux, F.; Bazureau, J. P. A practical access to novel 2-amino-5-arylidene-1,3-thiazol-4(5H)-ones via sulfur/nitrogen displacement under solvent-free microwave irradiation. Tetrahedron Lett. 2007, 48, 5785–5789.
   Web of Science ®Google Scholar
• Zvarec, O.; Polyak, S. W.; Tieu, W.; Kuan, K.; Dai, H.; Pedersen, D. S.; Morona, R.; Zhang, L.; Booker, G. W.; Abell, A. D. 5-Benzylidenerhodanine- and 5-benzylidene-2–4-thiazolidinedione-based antibacterials. Bioorg. Med. Chem. Lett. 2012, 22, 2720–2722.
   PubMed Web of Science ®Google Scholar
• Robertson, M. J.; Hadzic, G.; Ambrus, J.; Ambrus, J.; Pomè, D. Y.; Hyde, E.; Whiting, A.; Mariana, A.; VonKleist, L.; Chau, N.; Haucke, V.; Robinson, P. J.; McCluskey, A. The rhodadyns, a new class of small molecule inhibitors of dynamin GTPase activity. ACS Med. Chem. Lett. 2012, 3, 352–356.
   PubMed Web of Science ®Google Scholar
• Zidar, N.; Tomašić, T.; Šink, R.; Rupnik, V.; Kovac, A.; Turk, S.; Patin, D.; Blanot, D.; Contreras, M. C.; Dessen, A.; Müller, P. M.; Zega, A.; Gobec, S.; Peterlin, M. L.; Kikelj, D. Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase. J. Med. Chem. 2010, 53, 6584–6594.
   PubMed Web of Science ®Google Scholar
• Zidar, N.; Tomašić, T.; Šink, R.; Kovač, A.; Patin, D.; Blanot, D.; Contreras-Martel, C.; Dessen, A.; Premru, M. M.; Zega, A.; Gobec, S. Mašič, L. P.; Kikelj, D. New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: Design, synthesis, crystal structures, and biological evaluation. Eur. J. Med. Chem. 2011, 46, 5512–5523.
   PubMed Web of Science ®Google Scholar
• Song, M. X.; Zheng, C. J.; Deng, X. Q.; Wang, Q.; Hou, S. P.; Liu, T. T.; Xing, X. L.; Piao, H. R. Synthesis and bioactivity evaluation of rhodanine derivatives as potential anti-bacterial agents. Eur. J. Med. Chem. 2012, 54, 403–412.
   PubMed Web of Science ®Google Scholar
• (a) Suarez, A.; Downey, C. W.; Fu, G. C. Kinetic resolutions of azomethine imines via copper-catalyzed [3 + 2] cycloadditions. J. Am. Chem. Soc. 2005, 127, 11244–11245; (b) Shintani, R.; Fu, G. C. A new copper-catalyzed [3 + 2] cycloaddition: Enantioselective coupling of terminal alkynes with azomethine imines to generate five-membered nitrogen heterocycles. J. Am. Chem. Soc. 2003, 125, 10778–10779 (c) Imaizumi, T.; Yamashita, Y.; Kobayashi, S. Group 11 metal amide-catalyzed asymmetric cycloaddition reactions of azomethine imines with terminal alkynes. J. Am. Chem. Soc. 2012, 134, 20049–2005; (d) Oishi, T.; Yoshimura, K.; Yamaguchi, K.; Mizuno, N. An efficient copper-mediated 1,3-dipolar cycloaddition of pyrazolidinone-based dipoles to terminal alkynes to produce N,N-bicyclic pyrazolidinone derivatives. Chem. Lett. 2010, 39, 1086–1087; (e) Pezdirc, L.; Grošelj, U.; Meden, A.; Stanovnik, B.; Svete, J. 1,3-Dipolar cycloadditions of (4R*,5R*)-1-alkylidene-4-(benzoylamino)-5-phenyl-3-pyrazolidinon-1-azomethine imines. J. Heterocycl. Chem. 2008, 45, 181–188 (f) Keller, M.; Sido, A. S. S.; Pale, P.; Sommer, J. Copper(I) zeolites as heterogeneous and ligand-free catalysts: [3 + 2] Cycloaddition of azomethine imines. Chem. Eur. J. 2009, 15, 2810–2817; (h) Turk, C.; Golič, L.; Selič, L.; Svete, S.; Stanovnik, B. Stereoselective ring opening of dimethyl 5-aryl-2,3-dihydro-3,3-dimethyl-1-oxo-1H,5H-pyrazolo[1,2–a]pyrazole-6,7-dicarboxylates with hydrazine hydrate: Synthesis of rel-(4′R,5′S)-3-[5-aryl-3,4-bis(hydrazino-carbonyl)]-4,5-dihydro-1H-pyrazol-1-yl)-3-methylbutano-hydrazides. Arkivoc 2001, 5, 87–97.
   PubMed Web of Science ®Google Scholar
• (a) Pezdirc, L.; Jovanovski, V.; Bevk, D.; Jakše, R.; Pirc, S.; Meden, A.; Stanovnik, B.; Svete, J. Stereocontrol in cycloadditions of (1Z,4R*,5R*)-1-arylmethylidene-4-benzoyl amino-5-phenylpyrazolidin-3-on-1-azomethine imines. Tetrahedron 2005, 61, 3977–3990; (b) Chen, W.; Yuan, X. H.; Li, R.; Du, W.; Wu, Y.; Ding, L. S.; Chen, Y. C. Organocatalytic and stereoselective [3 + 2] cycloadditions of azomethine imines with α,β-unsaturated aldehydes. Adv. Synth. Catal. 2006, 348, 1818–1822.
   Web of Science ®Google Scholar
• (a) Chen, W.; Du, W.; Duan, Y. Z.; Wu, Y.; Yang, S. Y.; Chen, Y. C. Enantioselective 1,3-dipolar cycloaddition of cyclic enones catalyzed by multifunctional primary amines: Beneficial effects of hydrogen bonding. Angew. Chem. Int. Ed. 2007, 46, 7667–7670; (b) Sibi, M. P.; Rane, D.; Stanley, L. M.; Soeta, T. Copper(II)-catalyzed exo and enantioselective cycloadditions of azomethine imines. Org. Lett. 2008, 10, 2971–2974.
   PubMed Web of Science ®Google Scholar
• (a) Tanaka, K.; Kato, T.; Ukaji, Y.; Inomata, K. Catalytic asymmetric 1,3-dipolar cycloaddition of azomethine imines to allyl alcohol utilizing tartaric acid ester as a chiral auxiliary. Heterocycles 2010, 80, 887–893; (b) Ogawa, S.; Nishimine, T.; Tokunaga, E.; Shibata, N. Expeditious synthesis of trifluoromethylated heterocycles: Noncatalytic 1,3-dipolar cyclization of azomethine imines with (α -rifluoromethyl) acrylates. Synthesis 2010, 19, 3274–3281.
   Web of Science ®Google Scholar
• Xin, Y.; Zhao, J.; Gu, J.; Zhu, S. Catalyst-free 1,3-dipolar cycloaddition of 3-oxo-1,2-pyrazolidinium ylides to β-trifluoroacetyl vinyl ethyl ether: Synthesis of 6-trifluoroacetyl substituted bicyclic pyrazolidinones. J. Fluor. Chem. 2011, 132, 402–408.
   Web of Science ®Google Scholar
• Mloston, G.; Huisgen, R. Acid–base reactions of adamantanethione S-methylide and its spiro-1,3,4-thiadiazoline precursor. Tetrahedron 2001, 57, 145–151.
   Web of Science ®Google Scholar